29Sep
Regulatory Considerations for M&A Investors During COVID-19 - Era 3-Part Series: COVID-19’s Impact on US & Indian M&A Markets
The COVID-19 pandemic and the corresponding economic volatility has dramatically impacted the US and the Indian M&A market. While many high-profile companies have abandoned proposed deals, various other companies have expressed or maintained interest in pursuing strategic acquisitions during this time. This article discusses the regulatory changes that parties should consider when contemplating M&A events in the Indian and the US markets in the wake of COVID-19....
By:
Kilpatrick Townsend & Stockton LLP
Related
We are excited to bring the healthcare compliance sessions and updates to you as an interactive, onl...
Read More >
This blog has tried to stay apolitical throughout its 12+ years so I’m not going to start talking p...
Read More >
Seyfarth Synopsis: The Illinois Supreme Court recently affirmed that the Illinois Pollution Control ...
Read More >
Medical device and diagnostics companies and laboratories should anticipate significant legal, regul...
Read More >
Compliance into the Weeds is the only weekly podcast which takes a deep dive into a compliance relat...
Read More >
The plaintiff, an agricultural laborer, brought suit against his employer who, in turn, moved to com...
Read More >